571 results on '"Persson, F"'
Search Results
2. Nanoconfined circular and linear DNA - equilibrium conformations and unfolding kinetics
3. Orientational correlations in confined DNA
4. Photon generation in an electromagnetic cavity with a time-dependent boundary
5. Fast readout of a single Cooper-pair box using its quantum capacitance
6. Dressed Relaxation and Dephasing in a Strongly Driven Two-Level system
7. Excess dissipation in a single-electron box: The Sisyphus resistance
8. Fast tuning of superconducting microwave cavities
9. In-situ frequency tuning of photons stored in a high Q microwave cavity
10. Coherence times of dressed states of a superconducting qubit under extreme driving
11. The risk of symptomatic knee osteoarthritis after arthroscopic meniscus repair vs partial meniscectomy vs the general population
12. Charles of Bourbon, king of Southern Italy (1734–1759): The resilience of the Neapolitan ‘nation’, the development of reformism and the strength of the reaction
13. Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and renal disease as assessed by Steno Risk Engines in adults with type 1 diabetes
14. Biological Pre-Treatment for Improved Removal of Manganese in Chemical Drinking Water Treatment
15. Seaweed defence against bacteria : a poly-brominated 2-heptanone from the red alga Bonnemaisonia hamifera inhibits bacterial colonisation
16. Removal of organic micropollutants in the biological units of a Swedish wastewater treatment plant
17. Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment
18. A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
19. Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy
20. Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines
21. Achieving a useful and person-centred diabetes consultation is a shared responsibility between diabetologists and people with diabetes:a qualitative study of perspectives from people with type 1 diabetes
22. Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria:An IRMA2 sub-study
23. Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes
24. Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial
25. Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial
26. Assessment and clinical utility of a non-Next-Generation Sequencing based Non-Invasive Prenatal Testing technology
27. High-resolution array CGH analysis of salivary gland tumors reveals fusion and amplification of the FGFR1 and PLAG1 genes in ring chromosomes
28. A prediction model for end-stage kidney disease in type 1 diabetes in the presence of competing risk of death
29. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
30. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
31. Are interventions with dapagliflozin, metformin and exercise associated with changes in plasma glucagon concentrations in individuals with prediabetes? The PRE-D trial
32. Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes
33. Development and validation of a brief, descriptive Danish pain questionnaire (BDDPQ)
34. Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks™ HT
35. Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study
36. Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study
37. Achieving a useful and person‐centred diabetes consultation is a shared responsibility between diabetologists and people with diabetes: a qualitative study of perspectives from people with type 1 diabetes
38. Nanofluidics for single DNA molecule manipulation and analysis: E2.13
39. The influence on drawdown in a water power station due to eroded material in the outlet channel
40. Corrigendum to 'PAC dosing to an MBBR – Effects on adsorption of micropollutants, nitrification and microbial community' (Science of the Total Environment (2019) 677 (571–579), (S0048969719317966), (10.1016/j.scitotenv.2019.04.261))
41. Nanoelectrochemical transducers for (bio-) chemical sensor applications fabricated by nanoimprint lithography
42. Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors
43. Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors
44. Development and validation of a brief, descriptive Danish pain questionnaire (BDDPQ)
45. Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study.
46. Trajectories of estimated GFR in patients with and without albuminuria
47. Proportion of patients reaching HbA(1c) targets related to second-line treatment initiation: a Nordic observational study comparing type 2 diabetes management in primary care
48. Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes
49. Achieving a useful and person‐centred diabetes consultation is a shared responsibility between diabetologists and people with diabetes: a qualitative study of perspectives from people with type 1 diabetes.
50. The effect of uric acid lowering treatment on albuminuria and renal function in Type 1 diabetes:a randomized clinical trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.